Allergan Plc

Allergan Plc

Allergan Plc

Overview
Date Founded

1984

Headquarters

Clonshaugh Business & Tech. Park,Coolock,Dublin D17 E400

Type of Company

Public

Employees (Worldwide)

16.9K

Industries

Pharmaceuticals

Company Description

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

Contact Data
Trying to get in touch with decision makers at Allergan Plc? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chairman, President & Chief Executive Officer

Executive Vice President & Chief Financial Officer

Executive Vice President & Chief Commercial Officer

Secretary, Chief Legal Officer & Executive Vice President

Chief Accounting Officer

Chief Communications Officer

Chief R&D Officer

Vice President, Director of Finance & Assistant Corporate Secretary of Warner Chilcott Limited

Executive Vice President & Global Chief Compliance Officer

Executive Vice President

Board of Directors

Chairman, President & Chief Executive Officer at The Allergan Foundation

Co-Founder at Graybug Vision, Inc.

Former Chairman of the Board, President & Chief Executive Officer at Celgene Corp.

Former Vice President of Corporate Controller at Dell, Inc.

President at Abbott Laboratories (Puerto Rico), Inc.

Associate Chief & Clinical Director, Infectious Disease Division at The Massachusetts General Hospital

Director-FM Kirby Neurobiology Center at Boston Children’s Hospital

Chief Financial Officer at Dun & Bradstreet, Inc.

Advisory Partner at NewSpring Capital

Venture Partner at Flying Fish Management LLC

Paths to Allergan Plc
Potential Connections via
Relationship Science
You
Allergan Plc
Owners & Shareholders
Details Hidden

Wellington Management's investment services rely on their extensive independent research and include portfolio management styles and approaches in equities, fixed income securities, currencies and commodities, as well as asset allocation across these categories. The firm has a number of different disciplines when approaching research and these include asset allocation analysts, currency analysts, data scientists, factor analysts, fixed income credit analysts, fixed income market analysts, global industry analysts and research associates, macroanalysts, quantitative analysts and technical analysts. Wellington Management's portfolio management teams often include dedicated analysts who evaluate securities and other instruments for suitability based on the team's investment approach. The firm supplements their internal research with external research from sources such as broker/dealers and third-party research firms. These sources typically provide data, research and analysis and may serve as a gauge of market consensus.

Details Hidden

GIC-IM's investment teams manage a broad-based portfolio of asset classes. A focus on intrinsic value and price discipline guides them as they structure and pursue investment opportunities across asset classes and the capital structure. The team decides how to implement the asset policy mix in terms of the various investment strategies, proportion of funds to be actively/passively managed, allocation of risk capital and the selection of managers. The firm's portfolio managers then construct portfolios based on considerations of currency management, country selection, industry/sector allocation, yield curve management and security selection. GIC-IM's Board of Directors sets the policy asset mix and decides on a policy portfolio which specifies the allocation of funds to eligible asset classes. Investment decisions are based on analysis of fundamentals in line with long-term sustainable performance.

Details Hidden

Founded in 1998, UBS Securities LLC, formerly UBS Warburg LLC (U.S.), is an investment bank and registered broker/dealer located New York City. The firm is also a registered futures commission merchant. They are a subsidiary of UBS Americas, Inc. and their ultimate parent is UBS AG (NYSE: UBS). UBS Securities is a member of the NYSE, NASD, SIPC and FINRA.UBS Securities is a primary dealer in U.S. Government securities and provides a full range of investment banking services including corporate finance, mergers and acquisitions, capital markets, trading and sales, fixed-income, equity research, private banking, underwriting and prime brokerage operations. The firm also provides advisory services and access to capital markets for corporate, institutional, intermediary and alternative asset management clients. They offer closed-end fund research, commodity research, credit research, economic research, emerging market research, equity research, fixed-income research, foreign exchange research, real estate research, technical research and thematic research.

Recent Transactions
Details Hidden

AbbVie, Inc. purchases Allergan Plc

Details Hidden

Allergan Plc purchases Envy Medical, Inc. from HCP & Co.

Details Hidden

Allergan Plc purchases Bonti, Inc. from Colt Ventures Ltd., City Hill Ventures LLC, Highlight Capital, RusBio Ventures LLC

Transaction Advisors
Legal Advisor

Advised onAllergan Plc purchases Allergan, Inc.

Legal Advisor

Advised onAbbVie, Inc. purchases Allergan Plc

Legal Advisor

Advised onAllergan Plc purchases Zeltiq Aesthetics, Inc.

Legal Advisor

Advised onAllergan Plc purchases Zeltiq Aesthetics, Inc.

Legal Advisor

Advised onAllergan Plc purchases Zeltiq Aesthetics, Inc.

Legal Advisor

Advised onAllergan Plc purchases Zeltiq Aesthetics, Inc.

Advisors & Consultants
Legal Advisor

Partner at Gibson, Dunn & Crutcher LLP

Legal Advisor

Partner at Latham & Watkins LLP

Consultant

Former Senior Vice President, Finance & Treasurer at PepsiCo, Inc.

Clients

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. The company's products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. Amgen was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Cardinal Health, Inc. engages in the provision of pharmaceutical and medical products. It operates through the Pharmaceutical and Medical segments. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products in the United States. The Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The company was founded by Robert D. Walter in 1971 and is headquartered in Dublin, OH.

McKesson is dedicated to delivering the vital medicines, medical supplies and information technologies that enable the health care industry to provide patients better, safer care. McKesson is made up of many businesses, all serving the health care industry. Our businesses fall into one of two primary categories: Distribution solutions. We are the largest pharmaceutical distributor in North America, distributing one-third of the medicines used every day. As one of the leading pharmaceutical companies, we supply more than 40,000 U.S. pharmacy locations, from Wal-Mart to the Department of Veterans Affairs to community pharmacies and hospitals. McKesson is also one of the leading medical supply companies and distributes medical-surgical supplies and homecare supplies. Healthcare Technology solutions. We develop and install healthcare information technology systems that eliminate the need for paper prescriptions and paper medical records. Our software and hardware are used in more than 70% of the nation's hospitals with more than 200 beds. Our hospital information system solutions include electronic health record system (EHR) and clinical decision support system such as Interqual. McKesson's Healthcare IT division also serves diverse areas within the health industry by offering solutions such as pharmacy automation and medical claims management software. McKesson publicly traded on NYSE under MCK Businesses Serving our customers—pharmacies, medical and pharmaceutical manufacturers, hospitals, and insurers—as the health care industry evolves is our primary goal. We have business lines to automate processes from medical supplies packaging to claims management, and revenue cycle management to medical imaging. McKesson's long history in pharmaceutical industry History McKesson has a long history in health care. We’ve been a trusted provider of medical supplies and goods for more than 175 years.

Key Stats and Financials As of 2018
Market Capitalization
$52.4B
Total Enterprise Value
$67B
Earnings Per Share
$-15.26
Revenue
$15.8B
Net Profit
$-5.1B
Total Debt
$23.8B
Total Equity
$65.1B
Debt TEV
0.36x
EBITDA
$7.08B
EBITDAMargin
44.85%
Enterprise Value Sales
4.24x
Enterprise Value EBITDAOperating
9.45x
TEVNet Income
-13.14x
Five Year Compounded Annual Growth Rate Of Revenue
12.72%
Three Year Compounded Annual Growth Rate Of Revenue
1.56%
Investors
Details Hidden

Co-Founder at Longitude Capital Management Co. LLC

Details Hidden

Managing Partner at Vivo Capital LLC

Details Hidden

Investor at Neuronetics, Inc.

Suppliers
Antares Pharma, Inc. Hospitals & Patient Services | EWING, NJ

Antares Pharma is a revenue-generating product focused specialty pharmaceutical company that has developed three proprietary platforms, two of which now include FDA approved products. Our products typically improve safety and efficacy profiles by minimizing dosing and reducing side effects while improving patient compliance. We focus on self-injection pharmaceutical products and technologies and topical gel -based products. Our subcutaneous injection technology platforms include Vibex™ disposable pressure-assisted auto injectors, Vision® reusable needle-free injectors, and disposable multi-use pen injectors.

Ironwood Pharmaceuticals, Inc. Pharmaceuticals | Cambridge, Massachusetts

At Ironwood, we seek to transform knowledge into medicines that make a difference for patients. Patients shape our business. They influence our drugmaking process, helping us to understand and address their unmet medical needs, whether we’re creating a new medicine or tackling the equally challenging task of delivering that medicine to people around the world. Our employees shape our success. Since our founding in 1998, each of our employees has held shares in the company. Being owners of Ironwood means we are all careful stewards of our resources: we take a data-driven approach in which we celebrate definitive answers – whether those answers support holding steady or changing course – and we challenge every program to earn its way forward. Our discovery and development processes have generated a product that’s approved in the United States and in the European Union, as well as a robust pipeline. As we continue to do drugmaking well, we hope to inspire the support of our shareholders and earn the right to do it again – building an enduring pharmaceutical company that understands and addresses people’s needs.

The Chemical Works of Gedeon Richter Plc Pharmaceuticals | Budapest, BU

The Chemical Works of Gedeon Richter Plc engages in the development and manufacture of pharmaceuticals. It operates through the following segments: Pharmaceuticals, Wholesale and Retail, and Others. The Pharmaceutical segment engages in research and development, manufacturing, sales and marketing of pharmaceutical products. The Wholesale and Retail segment represents the distribution chain in the market which facilitate the product reaching the final buyers. The Other segment relates to the business of the members of the group that do not belong to any of the segments. The company was founded by Gedeon Richter in 1901 and is headquartered in Budapest, Hungary.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Allergan Plc. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Allergan Plc's profile does not indicate a business or promotional relationship of any kind between RelSci and Allergan Plc.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://news.relsci.com/organization/allergan-plc-115041376
  • https://news.relsci.com/organization/allergan-plc-115041376